Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

BET Bromodomain Blockade Enhances Ikaros Inhibition By Lenalidomide Therapy Providing Additional Activity in I n Vitro and In Vivo Models of Multiple Myeloma

Carlos Fernández de Larrea, Tania Díaz, Vanina Rodriguez, Ester Lozano, Patricia Pérez-Galán, Mari-Pau Mena, Marcos Calderón, Laura Rosiñol, Antonio Martínez, MD PhD, Natalia Tovar, Gael Roue, Joan Bladé

Blood (2016) 128 (22): 308.

https://doi.org/10.1182/blood.V128.22.308.308

Published: 2016

Journal Articles

Clinical Impact of the Presence of a Diffuse Large B-Cell Lymphoma (DLBCL) Component in the Outcome of Untreated Patients with Follicular Lymphoma (FL)

Laura Magnano, MD, Ivan Dlouhy, MD, Olga Balagué, MD, Alfredo Rivas-Delgado, MD, Jordina Rovira, MD, Kennosuke Karube, MD PhD, Blanca Gonzalez, MD, Alejandra Martinez-Trillos, MD, Antonio Martínez, MD PhD, Julio Delgado, Eva Gine, Neus Villamor, MD PhD, Elias Campo, MD PhD, Armando Lopez-Guillermo

Blood (2016) 128 (22): 3043.

https://doi.org/10.1182/blood.V128.22.3043.3043

Published: 2016

Journal Articles

Risk of Central Nervous System (CNS) Involvement in Patients with Mantle Cell Lymphoma (MCL): Analysis of Clinico-Biological Factors in a Series of 283 Cases

Blood (2014) 124 (21): 1677.

https://doi.org/10.1182/blood.V124.21.1677.1677

Published: 2014

Journal Articles

Piwirna-651 Expression Influences Treatment Response and Impacts Survival in Classical Hodgkin Lymphoma Patients through Regulation of ABCC5

Alfons Navarro, PhD, Anna Cordeiro, Msc, Anna Gaya, MD, Blanca Gonzalez-Farre, MD, Marina Díaz-Beyá, MD PhD, Dolors Fuster, Carmen Martínez, MD, Jordi Esteve, MD PhD, Antonio Martinez, MD, Mariano Monzó, MD PhD

Blood (2014) 124 (21): 134.

https://doi.org/10.1182/blood.V124.21.134.134

Published: 2014

Journal Articles

Prognostic Significance Of a 4-Microrna Signature Targeting JAK2 In Classical Hodgkin Lymphoma

Alfons Navarro, PhD, Anna Gaya, MD, Anna Cordeiro, Msc, Blanca Gonzalez-Farre, MD, Marina Díaz-Beyá, MD, Dolors Fuster, Carmen Martinez, Jordi Esteve, MD, PhD, Antonio Martinez, MD, Mariano Monzó, MD, PhD

Blood (2013) 122 (21): 629.

https://doi.org/10.1182/blood.V122.21.629.629

Published: 2013

Journal Articles

Mir-SNP Haplotype in the MicroRNA Maturation Pathway As a Marker of Clinical Outcome in Hodgkin Lymphoma (HL)

Alfons Navarro, PhD, Carmen Muñoz, PhD, Anna Gaya, MD, Antonio Martinez, MD, Marina Díaz Beyá, MD, Rut Tejero, Tania Díaz, PhD, Gerardo Ferrer, Msc, Alvaro Urbano-Ispizua, MD, Mariano Monzó, MD, PhD

Blood (2011) 118 (21): 1561.

https://doi.org/10.1182/blood.V118.21.1561.1561

Published: 2011

Journal Articles

Initial Features and Outcome Are Similar in Patients with Lymphoplasmacytic Lymphoma Regardless They Meet or Not Criteria of Waldenström Macroglobulinemia,

Eva Giné, MD, Jordina Rovira, MD, Alejandra Martinez-Trillos, MD, Neus Villamor, MD. PhD, Antonio Martinez, MD, Gonzalo Gutierrez-Garcia, MD, Luis Colomo, MD, Julio Delgado, MD, Tycho Stephan Baumann, MD, Elias Campo, MD, María Rozman, Armando Lopez-Guillermo, MD

Blood (2011) 118 (21): 3677.

https://doi.org/10.1182/blood.V118.21.3677.3677

Published: 2011

Journal Articles

Lestaurtinib (CEP701) Inhibits Proliferation and Activates Apoptosis In Hodgkin Lymphoma Cells through Inhibition of the JAK/STAT Signaling Pathway

Alfons Navarro, PhD, Tania Díaz, Antonio Martinez, MD, PhD, Anna Gaya, MD, Mariano Monzó, MD, PhD

Blood (2010) 116 (21): 3919.

https://doi.org/10.1182/blood.V116.21.3919.3919

Published: 2010

Journal Articles

Epigenetic Regulation of MicroRNA Expression In Hodgkin Lymphoma

Alfons Navarro, PhD, Tania Díaz, Marina Díaz Beyá, MD, Antonio Martinez, MD, PhD, Gerardo Ferrer, Kate E Hodgson, MD, Victor Ciria, Anna Gaya, MD, Mariano Monzó, MD, PhD

Blood (2010) 116 (21): 3885.

https://doi.org/10.1182/blood.V116.21.3885.3885

Published: 2010

Journal Articles

The Expression of the ER Stress Sensor GRP78/Bip Is a Target of R-CHOP and Bortezomib Treatments in DLBCL with Prognostic Value. A Rationale for the Use of Proteasome Inhibitors in DLBCL Patients.

Ana Mozos, Gael Roue, PhD, Armando López-Guillermo, Pedro Jares, Dolors Colomer, Elias Campo, MD, PhD, Antonio Martinez, MD, PhD

Blood (2009) 114 (22): 3734.

https://doi.org/10.1182/blood.V114.22.3734.3734

Published: 2009

Journal Articles

Formin-Like Gene Expression in Chronic Lymphocytic Leukemia Is Associated with Unfavorable Prognostic Factors and Clinical Outcome

Eva Calpe, PhD, Antonio Martinez, MD, PhD, Patricia Favaro, PhD, Marta Crespo, PhD, Carles Codony, PhD, Ma.ÂJoao Gomes Baptista, MSc, PharmD, Eva Gine, Emili Montserrat, MD, PhD, Francesc Bosch, MD, PhD

Blood (2008) 112 (11): 4181.

https://doi.org/10.1182/blood.V112.11.4181.4181

Published: 2008

Journal Articles

Regulation of Jak2 Kinase Gene by the Mir-135 Family in Classical Hodgkin Lymphoma

Alfons Navarro, PhD, Tania Diaz, Antonio Martinez, MD, PhD, Anna Gaya, MD, Aina Pons, Carmen Martinez, MD, Emili Montserrat, MD, PhD, Mariano Monzo, MD, PhD

Blood (2008) 112 (11): 518.

https://doi.org/10.1182/blood.V112.11.518.518

Published: 2008

Journal Articles

Gene Expression Signatures Predict Overall Survial in Diffuse Large B Cell Lymphoma Treated with Rituximab and Chop-Like Chemotherapy.

Georg Lenz, MD, George Wright, PhD, Sandeep Dave, MD, Alexander Kohlmann, PhD, Wenming Xiao, PhD, John Powell, MS, Hong Zhao, Weihong Xu, Randy D. Gascoyne, MD, Joseph M. Connors, MD, Lorraine May, MD, Dennis D. Weisenburger, MD, Tim Greiner, MD, Julie Vose, MD, James O. Armitage, MD, Javeed Iqbal, MD, Martin Bast, MD, Kai Fu, MD, Elias Campo, MD, Emili Montserrat, MD, Armando Lopez-Guillermo, MD, Pedro Jares, MD, Antonio Martinez, MD, Betty Gibbs, MD, Lisa M. Rimsza, MD, Richard I. Fisher, MD, Rita M. Braziel, MD, Ray Tubbs, MD, James Cook, MD, Brad Pohlman, MD, John Sweetenham, MD, Gunhild Troen, MD, Erlend B. Smeland, MD, Jan Delabie, MD, Stein Kvaloy, MD, Harald Holte, MD, Elaine S. Jaffe, MD, Wyndham H. Wilson, MD, Nicole Grant, MD, Elena Hartmann, MD, Andreas Rosenwald, MD, German Ott, MD, Hans-Konrad Muller-Hermelink, MD, T. Andrew Lister, MD, Mickey Williams, PhD, Lothar Wieczorek, PhD, Wing C. Chan, MD, Louis M. Staudt, MD, PhD

Blood (2007) 110 (11): 348.

https://doi.org/10.1182/blood.V110.11.348.348

Published: 2007

Journal Articles

Analysis of microRNA Patterns in Hodgkin’s Lymphoma (HL).

Alfons Navarro, PhD, Anna Gaya, MD, Aina Pons, PhD, Pau Abrisqueta, MD, Bernat Gel, PhD, Antonio Martinez, MD, PhD, Armando Lopez-Guillermo, MD, PhD, Carmen Martinez, MD, PhD, Miquel Granell, MD, Rosa Artells, PhD, Sonia Jansa, PhD, Alvaro Urbano-Ispizua, MD, PhD, Emili Montserrat, MD, PhD, Mariano Monzo, MD, PhD

Blood (2006) 108 (11): 474.

https://doi.org/10.1182/blood.V108.11.474.474

Published: 2006

NARROW

BET Bromodomain Blockade Enhances Ikaros Inhibition By Lenalidomide Therapy Providing Additional Activity in I n Vitro and In Vivo Models of Multiple Myeloma

Clinical Impact of the Presence of a Diffuse Large B-Cell Lymphoma (DLBCL) Component in the Outcome of Untreated Patients with Follicular Lymphoma (FL)

Risk of Central Nervous System (CNS) Involvement in Patients with Mantle Cell Lymphoma (MCL): Analysis of Clinico-Biological Factors in a Series of 283 Cases

Piwirna-651 Expression Influences Treatment Response and Impacts Survival in Classical Hodgkin Lymphoma Patients through Regulation of ABCC5

Prognostic Significance Of a 4-Microrna Signature Targeting JAK2 In Classical Hodgkin Lymphoma

Mir-SNP Haplotype in the MicroRNA Maturation Pathway As a Marker of Clinical Outcome in Hodgkin Lymphoma (HL)

Initial Features and Outcome Are Similar in Patients with Lymphoplasmacytic Lymphoma Regardless They Meet or Not Criteria of Waldenström Macroglobulinemia,

Lestaurtinib (CEP701) Inhibits Proliferation and Activates Apoptosis In Hodgkin Lymphoma Cells through Inhibition of the JAK/STAT Signaling Pathway

Epigenetic Regulation of MicroRNA Expression In Hodgkin Lymphoma

The Expression of the ER Stress Sensor GRP78/Bip Is a Target of R-CHOP and Bortezomib Treatments in DLBCL with Prognostic Value. A Rationale for the Use of Proteasome Inhibitors in DLBCL Patients.

Formin-Like Gene Expression in Chronic Lymphocytic Leukemia Is Associated with Unfavorable Prognostic Factors and Clinical Outcome

Regulation of Jak2 Kinase Gene by the Mir-135 Family in Classical Hodgkin Lymphoma

Gene Expression Signatures Predict Overall Survial in Diffuse Large B Cell Lymphoma Treated with Rituximab and Chop-Like Chemotherapy.

Analysis of microRNA Patterns in Hodgkin’s Lymphoma (HL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only